Anondita Medicare Ltd vs Gulf Lloyds India Ltd Stock Comparison
Anondita Medicare Ltd vs Gulf Lloyds India Ltd Stock Comparison
Last Updated on: Oct 31, 2026
Key Highlights
The Latest Trading Price of Anondita Medicare Ltd is ₹ 975.25 as of 30 Oct 15:30
. The P/E Ratio of Anondita Medicare Ltd is 0 as of March 2025
.The P/E Ratio of Gulf Lloyds (India) Ltd is 0 as of March 2025
. The Market Cap of Anondita Medicare Ltd is ₹ 0 crore as of March 2025
.The Market Cap of Gulf Lloyds (India) Ltd is ₹ 0 crore as of March 2025
. The Dividend Payout of Anondita Medicare Ltd is 0 % as of March 2024
.The Dividend Payout of Gulf Lloyds (India) Ltd is 0 % as of March 2024.
About Anondita Medicare Ltd
Anondita Medicare Limited was incorporated as a Public Limited Company on March 12, 2024, with the Registrar of Companies, Central Registration Centre.
Prior to this, Company business was run by current promoter, Mr. Anupam Ghosh, as a sole proprietorship under the name of M/s Anondita Healthcare (formerly M/s Healthcare Products) from year 1999 onwards.
Company is a manufacturer of male condoms with a variety of flavors, with our flagship product marketed and sold under the brand 'COBRA'.
It operate an installed production capacity of nearly 562 million condoms per annum, as per certificate issued by JP Sood, Chartered Engineer, dated November 21, 2024.
Further, to follow sustainable production practices, Company uses CNG as a clean, environmentally friendly manufacturing fuel for its manufacturing plant situated at Sector 80, Gautam Budh Nagar, Noida, Uttar Pradesh.
About Gulf Lloyds (India) Ltd
Gulf Lloyds (India) Limited was originally incorporated as 'Gulf Lloyads Industrial Services (India) Private Limited' dated September 26, 2014, with the Assistant Registrar of Companies, Gujarat.
Subsequently, the name of the company was changed to Gulf Lloyds Industrial Services (India) Private Limited and again was changed to Gulf Lloyds (India) Private Limited on September 10, 2024.
Thereafter, the name of the Company was changed to Gulf Lloyds (India) Limited vide fresh Certificate of Incorporation obtained from the Central Processing Centre on
January 20, 2025.
The Company is engaged in providing inspection, verification, auditing, training and certification for government bodies, public sector
enterprises, and private organizations engaged in infrastructure, industrial, and engineering activities and the testing services to clients operating across various industries.
FAQs for the comparison of Anondita Medicare Ltd and Gulf Lloyds (India) Ltd
Which company has a larger market capitalization, Anondita Medicare Ltd or Gulf Lloyds (India) Ltd?
Market cap of Anondita Medicare Ltd is 1,857 Cr while Market cap of Gulf Lloyds (India) Ltd is 26 Cr
What are the key factors driving the stock performance of Anondita Medicare Ltd and Gulf Lloyds (India) Ltd?
The stock performance of Anondita Medicare Ltd and Gulf Lloyds (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Anondita Medicare Ltd and Gulf Lloyds (India) Ltd?
As of October 31, 2026, the Anondita Medicare Ltd stock price is INR ₹975.25. On the other hand, Gulf Lloyds (India) Ltd stock price is INR ₹39.29.
How do dividend payouts of Anondita Medicare Ltd and Gulf Lloyds (India) Ltd compare?
To compare the dividend payouts of Anondita Medicare Ltd and Gulf Lloyds (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.